“C4IP panelists have made a number of phone calls. [the government and certain congress members’] The interpretation of Section 1498 is “legally incorrect” and “absurd,” and such an approach would not allow Americans to file private patent infringement bills in the tone of multi-million dollar damages. Said he would do it.
From top left: Frank Cullen, Brian Oshognessy, Adam Mozoff, Ev Bright, Judge Susan Braden
The Council for Promoting Innovation (C4IP) will host a webinar on Monday featuring prominent figures in the IP world, highlighting what the organization has characterized as an erroneous view of the use of Title 28, Section 1498(a) of the United States Code. clarified. The event was prompted in part by a recent US government statement of interest filed in Moderna’s patent infringement lawsuit against his COVID-19 vaccine. The statement argued that Moderna “should be released from liability for infringement under the terms of the permitting government contract.”[d] agree with[ed] Applies to all uses and manufactures of U.S. patented inventions.
The statement of interest was made in the context of the lawsuit filed against Moderna by Arbutus Biopharma and Genevant Sciences. In response to Judge Mitchell Goldberg’s request for a briefing on Government Expressions of Interest, the United States has filed infringement damages against Moderna, not Moderna, under one of the two government contracts at issue in the lawsuit. filed a short letter further alleging that it was responsible for According to the government, Moderna was under the direct control of the government through the express grant of a license and consent agreement to use and manufacture the patented invention embodied in Moderna’s vaccine, Section 1498. requirements based on are eliminated. Consent was only implied.
Arbutus argues, however, that section 1498 requires defendants to show that the alleged patent infringement was “for the benefit of the government” and with the government’s “permission and consent.” I objected. Government is a factual dispute that can only be resolved with a fully developed record.[W[hetherModerna’sinfringementwasforthebenefitoftheUSpopulationortheGovernmentisafactualdisputethatcanonlyberesolvedonafullydevelopedrecord”[W[hetherModerna’sinfringementwasforthebenefitoftheUSpopulationortheGovernmentisafactualdisputethatcanonlyberesolvedonafullydevelopedrecord”
In addition to expressing interest, C4IP executive director Frank Cullen said yesterday that certain members of Congress have urged HHS Secretary Xavier Becerra to abuse Section 1498 to lower drug prices. explained that there is In a letter dated June 23, 2022, Senators Elizabeth Warren (D-Massachusetts), Rep. Lloyd Doggett (D-Texas), and colleagues in 98 Democrats urged Mr. I wrote a letter urging them to take advantage of administrative authorities, including Licensing under 28 USC 1498 and march-in and royalty-free rights under the Bayh-Dole Act to lower the price of prescription drugs. According to the letter, his 80% of voters support breaking patents to bring down drug prices, and the use of tools like Section 1498 is an extension of President Biden’s executive order on promoting competition in the American economy. is an obligation. “The use of patent licensing agencies under these laws could open up generic or biosimilar competition and drive down prices dramatically in the coming months,” the letter added. I was.
However, C4IP panelists variously called this interpretation of Section 1498 “illegal” and “ridiculous,” and such an approach could cost Americans millions of dollars in damages. He said he would only submit a private patent infringement bill in .
history lesson
Professor Adam Mossoff of Antonin Scalia Law School said part of the problem is rooted in a fundamental misunderstanding of the history and intent of law. Section 1498, he explained, was his 100-year-old law first enacted by Congress in 1910 and amended in 1918 and 1941. It sets out the conditions under which patent owners may obtain compensation. It designates the Court of Federal Claims as the venue for patent owners to obtain “reasonable and complete compensation.” Around 19:00th Mossoff pointed out that courts consistently uphold the rights of patent owners through the Fifth Amendment acquisition clause and require payment for government infringement of the owners. However, the Supreme Court ruled he caused confusion at the end of 19.th A century of protection by several decisions that led to Congress stepping in to resolve uncertainties in 1910. .
investment reality
Earl “Eb” Bright, president and general counsel at ExploraMed, a venture-backed medical device incubator, told the panel when investing in high-risk areas like medical devices: We make tens of millions, if not more than $100 million, in profits doing preclinical and clinical trials, so we have strong intellectual property before we go down that long and broad road. It is very important to be “
Mr Bright said Section 1498 was created to promote a balance between intellectual property rights and encouraging private industry to provide needed products to the government, and that the statement of interest As suggested, a dramatic shift in balance could disappoint investors, he said. “If they step in and try to deprive private industry of his IP, they will discourage future investment in new underlying technologies,” Bright said. If it takes him 10 years and he nearly $2 billion to bring a product to market in the pharmaceutical sector, this takes time and investment to get insurance companies and contract manufacturers to pay for it. is not included. Along the way, they’ve earned a return on investment. If we throw the balance off by changing the law along the way, it will discourage future investment,” Bright added.
The panel also included Judge Susan Braden, former Chief Justice of the Court of Federal Claims. Braden has been a vocal opponent of calls for abuse of Section 1498, saying in a recent article in IPWatchdog that Judge Goldberg recognizes the far-reaching implications of signing the government’s position. Goldberg said, “I recognized the dangerous implications of the Justice Department’s position, which is that every government-funded product goes from IV needles to fight HIV to cancer drugs to fight the war on cancer.” , means that it could be meant to be used to advance policy objectives articulated by the U.S. government — would be subject to the defense of §1498(a),” Braden said. wrote.
absolutely ridiculous
Braden told the panel that he has worked in the Court of Federal Claims for more than 17 years and has served as chief adjudicator in many cases arising under 1498(a). “Almost all of them were for traditional military or government use cases,” she said.But since lawmakers began citing Mr. Braden’s statements, they have been data-poor and legally inaccurate. Yale Law Review This kind of misuse has become more common as the passage of Section 1498(a) was enacted, calling for adoption of the law to reduce drug prices. Mr. Braden said the idea that the government could actually lower drug prices through Section 1498(a) was “absolutely ridiculous,” firstly because it cannot be used as a matter of law, and secondly, because it cannot be used as a matter of law. results in reduced drug costs. “It would impose a tax on the general public,” commented Braden.
She acknowledged that there are few brand-name medicines with high prices today (most brand-name medicines are comparable to generics and covered by government schemes, she noted). , because only a handful of people use them. A very limited time frame for investors to get their money back. “Investors who put money into some of these blockbuster drugs that have taken years to develop have a very short period of time before they see a return on their investment. , with only a few years left on the patent, Braden said this raises a lot of questions about potential alternatives to keep the prices of these blockbuster drugs low. It’s not that way, nor is it going to bring down the price of medicine.”
old experiment
Ultimately, the Panel cautioned against the potentially disastrous consequences of misusing and misinterpreting Section 1498, including national security risks. “The false premise is that if we simply seize property rights, everything will be readily available and innovation will fall from the sky like manna from heaven.” He also served as the society’s senior vice president of public policy.
“We ran experiments. Before the Bayh-Dole Act, when universities could not take ownership of inventions simply because they had little funding from the federal government, university research There have been no drugs coming out of the lab, and there have been over 300 FDA-approved drugs since the Bayh-Dole Act went into effect, so the ability to rely on IP protection to encourage investment and take risks It’s clearly been profitable.Stop reinventing the wheel.”
